Standardized incidence rate of 1-year and 2-year risk of death and peritonitis
| . | 1-year outcomes (%) . | 2-year outcomes (%) . | ||||
|---|---|---|---|---|---|---|
| Time period . | Crude . | + Age, sex . | + Comorbiditya . | Crude . | + Age, sex . | + Comorbiditya . |
| Death | ||||||
| 2006–2007 | 8.8 | 9.1 | 8.1 | 16.7 | 17.2 | 15.3 |
| 2008–2009 | 8.6 | 8.5 | 7.5 | 18.6 | 17.9 | 15.7 |
| 2010–2011 | 8.6 | 7.8 | 7.1 | 18.7 | 17.2 | 16.7 |
| 2012–2013 | 9.3 | 9.2 | 8.0 | 18.0 | 18.0 | 14.8 |
| 2014–2015 | 7.0 | 7.4 | 7.2 | 15.8 | 16.3 | 14.5 |
| MACEsb | ||||||
| 2005–2006 | 12.8 | 13.0 | 11.4 | 20.6 | 20.8 | 17.7 |
| 2007–2008 | 14.8 | 14.9 | 14.0 | 23.0 | 22.9 | 21.3 |
| 2009–2010 | 13.6 | 13.1 | 12.2 | 21.0 | 20.4 | 19.2 |
| 2011–2012 | 13.6 | 13.1 | 12.4 | 22.8 | 22.3 | 20.3 |
| 2013–2014 | 13.8 | 14.4 | 13.0 | 20.6 | 21.5 | 19.2 |
| Kidney transplant | ||||||
| 2005–2006 | 6.8 | 6.5 | 5.9 | 15.9 | 15.3 | 14.7 |
| 2007–2008 | 8.8 | 8.7 | 8.3 | 16.1 | 15.5 | 14.6 |
| 2009–2010 | 8.6 | 9.0 | 7.8 | 15.1 | 15.6 | 13.8 |
| 2011–2012 | 10.8 | 11.2 | 10.0 | 19.7 | 20.4 | 18.6 |
| 2013–2014 | 10.3 | 9.9 | 9.5 | 20.6 | 20.5 | 18.6 |
| Peritonitis | ||||||
| 2005–2006 | 21.0 | 20.9 | 19.4 | 32.0 | 31.7 | 29.3 |
| 2007–2008 | 21.2 | 21.1 | 19.7 | 28.9 | 28.9 | 27.0 |
| 2009–2010 | 20.4 | 21.0 | 19.3 | 27.6 | 27.8 | 26.1 |
| 2011–2012 | 14.8 | 14.6 | 12.9 | 24.1 | 24.5 | 22.9 |
| 2013–2014 | 18.0 | 17.9 | 16.4 | 24.3 | 24.3 | 22.0 |
| Transfer to HD | ||||||
| 2006–2007 | 12.2 | 11.9 | 11.1 | 25.5 | 25.1 | 24.1 |
| 2008–2009 | 16.7 | 17.1 | 16.0 | 27.6 | 28.0 | 26.0 |
| 2010–2011 | 12.6 | 13.7 | 13.1 | 23.7 | 24.9 | 24.1 |
| 2012–2013 | 10.2 | 9.8 | 8.9 | 21.3 | 20.6 | 19.5 |
| 2014–2015 | 13.3 | 13.0 | 12.5 | 25.1 | 24.3 | 23.1 |
| . | 1-year outcomes (%) . | 2-year outcomes (%) . | ||||
|---|---|---|---|---|---|---|
| Time period . | Crude . | + Age, sex . | + Comorbiditya . | Crude . | + Age, sex . | + Comorbiditya . |
| Death | ||||||
| 2006–2007 | 8.8 | 9.1 | 8.1 | 16.7 | 17.2 | 15.3 |
| 2008–2009 | 8.6 | 8.5 | 7.5 | 18.6 | 17.9 | 15.7 |
| 2010–2011 | 8.6 | 7.8 | 7.1 | 18.7 | 17.2 | 16.7 |
| 2012–2013 | 9.3 | 9.2 | 8.0 | 18.0 | 18.0 | 14.8 |
| 2014–2015 | 7.0 | 7.4 | 7.2 | 15.8 | 16.3 | 14.5 |
| MACEsb | ||||||
| 2005–2006 | 12.8 | 13.0 | 11.4 | 20.6 | 20.8 | 17.7 |
| 2007–2008 | 14.8 | 14.9 | 14.0 | 23.0 | 22.9 | 21.3 |
| 2009–2010 | 13.6 | 13.1 | 12.2 | 21.0 | 20.4 | 19.2 |
| 2011–2012 | 13.6 | 13.1 | 12.4 | 22.8 | 22.3 | 20.3 |
| 2013–2014 | 13.8 | 14.4 | 13.0 | 20.6 | 21.5 | 19.2 |
| Kidney transplant | ||||||
| 2005–2006 | 6.8 | 6.5 | 5.9 | 15.9 | 15.3 | 14.7 |
| 2007–2008 | 8.8 | 8.7 | 8.3 | 16.1 | 15.5 | 14.6 |
| 2009–2010 | 8.6 | 9.0 | 7.8 | 15.1 | 15.6 | 13.8 |
| 2011–2012 | 10.8 | 11.2 | 10.0 | 19.7 | 20.4 | 18.6 |
| 2013–2014 | 10.3 | 9.9 | 9.5 | 20.6 | 20.5 | 18.6 |
| Peritonitis | ||||||
| 2005–2006 | 21.0 | 20.9 | 19.4 | 32.0 | 31.7 | 29.3 |
| 2007–2008 | 21.2 | 21.1 | 19.7 | 28.9 | 28.9 | 27.0 |
| 2009–2010 | 20.4 | 21.0 | 19.3 | 27.6 | 27.8 | 26.1 |
| 2011–2012 | 14.8 | 14.6 | 12.9 | 24.1 | 24.5 | 22.9 |
| 2013–2014 | 18.0 | 17.9 | 16.4 | 24.3 | 24.3 | 22.0 |
| Transfer to HD | ||||||
| 2006–2007 | 12.2 | 11.9 | 11.1 | 25.5 | 25.1 | 24.1 |
| 2008–2009 | 16.7 | 17.1 | 16.0 | 27.6 | 28.0 | 26.0 |
| 2010–2011 | 12.6 | 13.7 | 13.1 | 23.7 | 24.9 | 24.1 |
| 2012–2013 | 10.2 | 9.8 | 8.9 | 21.3 | 20.6 | 19.5 |
| 2014–2015 | 13.3 | 13.0 | 12.5 | 25.1 | 24.3 | 23.1 |
Standardized incidence rates of 1- and 2-year outcomes were performed with logistic regression models.
Comorbidity included hypertension, diabetes, cardiovascular disease, stroke, atrial fibrillation, chronic obstructive pulmonary disease, rheumatoid disease and cancer.b MACEs included cardiovascular death, hospitalization of re-infarction, stroke and heart failure.
Standardized incidence rate of 1-year and 2-year risk of death and peritonitis
| . | 1-year outcomes (%) . | 2-year outcomes (%) . | ||||
|---|---|---|---|---|---|---|
| Time period . | Crude . | + Age, sex . | + Comorbiditya . | Crude . | + Age, sex . | + Comorbiditya . |
| Death | ||||||
| 2006–2007 | 8.8 | 9.1 | 8.1 | 16.7 | 17.2 | 15.3 |
| 2008–2009 | 8.6 | 8.5 | 7.5 | 18.6 | 17.9 | 15.7 |
| 2010–2011 | 8.6 | 7.8 | 7.1 | 18.7 | 17.2 | 16.7 |
| 2012–2013 | 9.3 | 9.2 | 8.0 | 18.0 | 18.0 | 14.8 |
| 2014–2015 | 7.0 | 7.4 | 7.2 | 15.8 | 16.3 | 14.5 |
| MACEsb | ||||||
| 2005–2006 | 12.8 | 13.0 | 11.4 | 20.6 | 20.8 | 17.7 |
| 2007–2008 | 14.8 | 14.9 | 14.0 | 23.0 | 22.9 | 21.3 |
| 2009–2010 | 13.6 | 13.1 | 12.2 | 21.0 | 20.4 | 19.2 |
| 2011–2012 | 13.6 | 13.1 | 12.4 | 22.8 | 22.3 | 20.3 |
| 2013–2014 | 13.8 | 14.4 | 13.0 | 20.6 | 21.5 | 19.2 |
| Kidney transplant | ||||||
| 2005–2006 | 6.8 | 6.5 | 5.9 | 15.9 | 15.3 | 14.7 |
| 2007–2008 | 8.8 | 8.7 | 8.3 | 16.1 | 15.5 | 14.6 |
| 2009–2010 | 8.6 | 9.0 | 7.8 | 15.1 | 15.6 | 13.8 |
| 2011–2012 | 10.8 | 11.2 | 10.0 | 19.7 | 20.4 | 18.6 |
| 2013–2014 | 10.3 | 9.9 | 9.5 | 20.6 | 20.5 | 18.6 |
| Peritonitis | ||||||
| 2005–2006 | 21.0 | 20.9 | 19.4 | 32.0 | 31.7 | 29.3 |
| 2007–2008 | 21.2 | 21.1 | 19.7 | 28.9 | 28.9 | 27.0 |
| 2009–2010 | 20.4 | 21.0 | 19.3 | 27.6 | 27.8 | 26.1 |
| 2011–2012 | 14.8 | 14.6 | 12.9 | 24.1 | 24.5 | 22.9 |
| 2013–2014 | 18.0 | 17.9 | 16.4 | 24.3 | 24.3 | 22.0 |
| Transfer to HD | ||||||
| 2006–2007 | 12.2 | 11.9 | 11.1 | 25.5 | 25.1 | 24.1 |
| 2008–2009 | 16.7 | 17.1 | 16.0 | 27.6 | 28.0 | 26.0 |
| 2010–2011 | 12.6 | 13.7 | 13.1 | 23.7 | 24.9 | 24.1 |
| 2012–2013 | 10.2 | 9.8 | 8.9 | 21.3 | 20.6 | 19.5 |
| 2014–2015 | 13.3 | 13.0 | 12.5 | 25.1 | 24.3 | 23.1 |
| . | 1-year outcomes (%) . | 2-year outcomes (%) . | ||||
|---|---|---|---|---|---|---|
| Time period . | Crude . | + Age, sex . | + Comorbiditya . | Crude . | + Age, sex . | + Comorbiditya . |
| Death | ||||||
| 2006–2007 | 8.8 | 9.1 | 8.1 | 16.7 | 17.2 | 15.3 |
| 2008–2009 | 8.6 | 8.5 | 7.5 | 18.6 | 17.9 | 15.7 |
| 2010–2011 | 8.6 | 7.8 | 7.1 | 18.7 | 17.2 | 16.7 |
| 2012–2013 | 9.3 | 9.2 | 8.0 | 18.0 | 18.0 | 14.8 |
| 2014–2015 | 7.0 | 7.4 | 7.2 | 15.8 | 16.3 | 14.5 |
| MACEsb | ||||||
| 2005–2006 | 12.8 | 13.0 | 11.4 | 20.6 | 20.8 | 17.7 |
| 2007–2008 | 14.8 | 14.9 | 14.0 | 23.0 | 22.9 | 21.3 |
| 2009–2010 | 13.6 | 13.1 | 12.2 | 21.0 | 20.4 | 19.2 |
| 2011–2012 | 13.6 | 13.1 | 12.4 | 22.8 | 22.3 | 20.3 |
| 2013–2014 | 13.8 | 14.4 | 13.0 | 20.6 | 21.5 | 19.2 |
| Kidney transplant | ||||||
| 2005–2006 | 6.8 | 6.5 | 5.9 | 15.9 | 15.3 | 14.7 |
| 2007–2008 | 8.8 | 8.7 | 8.3 | 16.1 | 15.5 | 14.6 |
| 2009–2010 | 8.6 | 9.0 | 7.8 | 15.1 | 15.6 | 13.8 |
| 2011–2012 | 10.8 | 11.2 | 10.0 | 19.7 | 20.4 | 18.6 |
| 2013–2014 | 10.3 | 9.9 | 9.5 | 20.6 | 20.5 | 18.6 |
| Peritonitis | ||||||
| 2005–2006 | 21.0 | 20.9 | 19.4 | 32.0 | 31.7 | 29.3 |
| 2007–2008 | 21.2 | 21.1 | 19.7 | 28.9 | 28.9 | 27.0 |
| 2009–2010 | 20.4 | 21.0 | 19.3 | 27.6 | 27.8 | 26.1 |
| 2011–2012 | 14.8 | 14.6 | 12.9 | 24.1 | 24.5 | 22.9 |
| 2013–2014 | 18.0 | 17.9 | 16.4 | 24.3 | 24.3 | 22.0 |
| Transfer to HD | ||||||
| 2006–2007 | 12.2 | 11.9 | 11.1 | 25.5 | 25.1 | 24.1 |
| 2008–2009 | 16.7 | 17.1 | 16.0 | 27.6 | 28.0 | 26.0 |
| 2010–2011 | 12.6 | 13.7 | 13.1 | 23.7 | 24.9 | 24.1 |
| 2012–2013 | 10.2 | 9.8 | 8.9 | 21.3 | 20.6 | 19.5 |
| 2014–2015 | 13.3 | 13.0 | 12.5 | 25.1 | 24.3 | 23.1 |
Standardized incidence rates of 1- and 2-year outcomes were performed with logistic regression models.
Comorbidity included hypertension, diabetes, cardiovascular disease, stroke, atrial fibrillation, chronic obstructive pulmonary disease, rheumatoid disease and cancer.b MACEs included cardiovascular death, hospitalization of re-infarction, stroke and heart failure.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
